Mounjaro i antykoncepcja: co każda kobieta powinna wiedzieć

You've started Mounjaro and you're still on the pill, here's what's actually happening

Picture the scene: your first Mounjaro pen has arrived, you've given yourself the 2.5mg starter dose, and everything feels routine. The pill you take every morning is still sitting on the bathroom shelf. Nothing's changed, right?

In practice, something significant has shifted. Mounjaro works partly by slowing down how quickly your stomach empties into the small intestine, that's one of the mechanisms behind the appetite reduction and steadier blood sugar it produces. The same slowing applies to everything you swallow, including oral contraceptive tablets. If a pill spends longer in the stomach before being absorbed, the amount that eventually reaches your bloodstream can be lower or less predictable than usual.

For most oral medicines this is a minor footnote. For the contraceptive pill, it matters more, because the margin for reliable protection is already relatively narrow. NHS England's guidance on weight-management injections is explicit on this point: women using oral contraceptives should use an additional, non-oral contraceptive method for the first four weeks of tirzepatide treatment. The same four-week window applies each time the dose increases, because every step up brings a fresh adjustment in gastric motility.

That's the practical upshot. A barrier method (condoms are the obvious choice) covers the gap without requiring any changes to your existing prescription. You're not being asked to stop your pill; you're being asked to add a layer during the transition periods.

Why this is specific to Mounjaro and not to every weight-loss injection

A fair question comes up often: does this apply to Wegovy (semaglutide) too? The honest answer, based on current evidence, is that no equivalent concern has been identified for the injectable form of semaglutide. NHS guidance draws this distinction clearly. The gastric-emptying effect exists across GLP-1 medicines to varying degrees, but the clinical signal strong enough to generate a specific contraception warning has, so far, attached to tirzepatide.

That distinction matters if you're weighing up treatment options, and it's the kind of nuance that gets discussed during a consultation rather than spotted on a packaging leaflet at home. If you'd like to understand how the two medicines differ more broadly, the overview of Mounjaro as a weight-loss treatment covers the mechanism in more detail, and our prescribers can talk through which option suits your circumstances.

It's also worth knowing that this interaction has nothing to do with the effectiveness of Mounjaro itself as a weight-loss medicine. It reflects tirzepatide's mechanism acting on the gut, the same mechanism that produces the appetite suppression and metabolic effects that make it clinically effective. The side and the signal come from the same source.

For anyone curious about pricing while researching treatment, the Mounjaro cost page explains how private treatment is structured and what a transparent price includes, that's naturally a separate question from the clinical one here.

Pregnancy, planning ahead, and when Mounjaro is not appropriate at all

We know that many women starting a weight-loss medicine are thinking carefully about their reproductive plans, and it's completely understandable to want clarity on this, not just reassurance. So here it is plainly.

Mounjaro is not licensed for use during pregnancy. It is not recommended while breastfeeding. And for women who are actively trying to conceive, it is not an appropriate treatment. If your situation changes and you want to start trying for a pregnancy, you and your prescriber will need to plan a wash-out period before stopping contraception; the MHRA advises using contraception throughout treatment and for a period after stopping, and your prescriber will advise on the timing based on current guidance.

On the other side of that: if you're not planning a pregnancy and you're starting Mounjaro, the advice is to ensure your contraception is reliable and to add that back-up method during the four-week windows described above. Any questions about how your specific contraceptive method interacts with Mounjaro (whether you're on the combined pill, the progestogen-only pill, or considering a switch) are exactly what a consultation is for. The Mounjaro concerns page addresses a wider range of questions patients bring before they start.

The MHRA's Yellow Card scheme is also there if you notice anything unexpected once treatment is underway, reporting side effects, including anything that makes you think your contraception may have been affected, helps build the evidence base for everyone.

Practical steps before your first dose

Our prescribers hear this question regularly, usually from women who've done their research and want to get the detail right before they start, not after. That's exactly the right instinct.

Before your first injection: check which type of contraceptive you're using and, if it's an oral method, have a non-oral back-up ready from day one. You don't need to obtain anything complicated, condoms work, and they're available without any prescription or advance planning. Mark the date your four-week window ends, because once it passes you don't need to maintain the extra method until your next dose increase.

Mounjaro is a once-weekly injection, which makes dose-increase dates predictable, and if you've ever wondered whether taking Mounjaro more than once a week is possible, the short answer is no, though that page explains the reasoning in full. You'll know exactly when you move from 2.5mg to 5mg, for instance, and can restart your four-week back-up window from that point. Storage and handling between doses matters too; the guidance on what to do with a Mounjaro pen once it's been opened is worth reading before you start.

If you have questions at any point during treatment, our team is available seven days a week. Treatment at nume is dispensed through our GPhC-registered pharmacy (registration number 9012878, verifiable at pharmacyregulation.org), and every consultation is reviewed by a named, qualified prescriber. Ready to take the next step? Check your eligibility and speak with our prescribers about whether Mounjaro is right for you.